Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
To assess the effects of i.v. zoledronic acid 4 mg with respect to safety and tolerability
Prostate Cancer
DRUG: Zoledronic acid
To evaluate the tolerability and safey of zoledronic acid 4mg, IV, for the following eficacy metrics: QoL, Safety (Aes) and evaluation of pain
No secondary outcomes/objectives planned
To assess the effects of i.v. zoledronic acid 4 mg with respect to safety and tolerability